You are Trying to View a Premium ArticleDaily News You Can't Find Anywhere Else
Lupin Bets Big on Oncology in AbbVie-Partnership, Could Garner $1 Billion+, an Industrial Info Market Brief
Industry Segment: Pharmaceutical & Biotech | Word Count: 113 Words
Attachment: Lupin Pharma 0119
Indian pharmaceutical company Lupin Limited is eyeing major growth in its portfolio through a Novel Drug Discovery and Development (NDDD) program, focused on oncology, immunology and metabolic disorders
This Premium Article can be purchased individually or as part of a subscription
Subscribe Now! All Fields Required...
- Onshore Oil & Gas Registers 21.6% Gain in Industrial Info's North American ...
- Europe to See $3.5 Billion in Pharma-Biotech Projects Kick Off this Quarter...
- U.S. FDA Clears Indoco's Goa Plants, an Industrial Info Market Brief
- Biosimilars to Help India's Biocon to Hit $1 Billion in Revenue, an Industr...
- Bangladesh's Pharmaceutical Exports Up 25%, an Industrial Info Market Brief
- Current Economic Indicators
- Free Daily Industrial Articles
- Monthly Industrial Newsletter
- IIR's Disaster Impact Tracker